Wednesday, November 15, 2017 10:15 PM ET
Insider purchase at Wave Life Sciences (WVE) comes in face of Selling Trend of Last 90 Days
There was a noteworthy insider purchase in Wave Life Sciences shares today as revealed in a filing with the SEC. One insider — RA Capital Management LLC, 10% Owner and Director — bought 423,398 shares in the company having a net market value of approximately $9,881,550. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 20,747 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 402,651 shares and have averaged 222,073 shares per transaction over this time period.
The number of insider buy/sell trades at Wave Life Sciences is greater than that of the 186 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 200 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Wave Life Sciences insiders is lower than its peers. Within the peer group there were 22,481,651 shares purchased and 31,895,627 shares sold with company insiders disposing of 47,070 shares on average over this time period.
The data used in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.